TY - JOUR
T1 - Hirschsprung's disease prevalence in Europe: A register based study
AU - Best, Kate E
AU - Addor, Marie-Claude
AU - Arriola, Larraitz
AU - Balku, Eszter
AU - Barisic, Ingeborg
AU - Bianchi, Fabrizio
AU - Calzolari, Elisa
AU - Curran, Rhonda
AU - Doray, Berenice
AU - Draper, Elizabeth
AU - Garne, Ester
AU - Gatt, Miriam
AU - Haeusler, Martin
AU - Bergman, Jorieke
AU - Khoshnood, Babak
AU - Klungsoyr, Kari
AU - Martos, Carmen
AU - Materna-Kiryluk, Anna
AU - Matias Dias, Carlos
AU - McDonnell, Bob
AU - Mullaney, Carmel
AU - Nelen, Vera
AU - O'Mahony, Mary
AU - Queisser-Luft, Annette
AU - Randrianaivo, Hanitra
AU - Rissmann, Anke
AU - Rounding, Catherine
AU - Sipek, Antonin
AU - Thompson, Rosie
AU - Tucker, David
AU - Wellesley, Diana
AU - Zymak-Zakutnia, Natalya
AU - Rankin, Judith
PY - 2014/9
Y1 - 2014/9
N2 - Background: Hirschsprung's disease is a congenital gut motility disorder, characterised by the absence of the enteric ganglion cells along the distal gut. The aim of this study was to describe the epidemiology of Hirschsprung's disease, including additional congenital anomalies, total prevalence, trends, and association with maternal age. Methods: Cases of Hirschsprung's disease delivered during 1980 to 2009 notified to 31 European Surveillance of Congenital Anomaly registers formed the population-based case-series. Prevalence rates and 95% confidence intervals were calculated as the number of cases per 10,000 births. Multilevel Poisson regression was performed to investigate trends in prevalence, geographical variation and the association with maternal age. Results: There were 1,322 cases of Hirschsprung's disease among 12,146,210 births. The total prevalence was 1.09 (95% confidence interval, 1.03–1.15) per 10,000 births and there was a small but significant increase in prevalence over time (relative risk = 1.01; 95% credible interval, 1.00–1.02; p = 0.004). There was evidence of geographical heterogeneity in prevalence (p < 0.001). Excluding 146 (11.0%) cases with chromosomal anomalies or genetic syndromes, there were 1,176 cases (prevalence = 0.97; 95% confidence interval, 0.91–1.03 per 10,000 births), of which 137 (11.6%) had major structural anomalies. There was no evidence of a significant increased risk of Hirschsprung's disease in cases born to women aged ≥35 years compared with those aged 25 to 29 (relative risk = 1.09; 95% credible interval, 0.91–1.31; p = 0.355). Conclusion: This large population-based study found evidence of a small increasing trend in Hirschsprung's disease and differences in prevalence by geographic location. There was also no evidence of an association with maternal age.
AB - Background: Hirschsprung's disease is a congenital gut motility disorder, characterised by the absence of the enteric ganglion cells along the distal gut. The aim of this study was to describe the epidemiology of Hirschsprung's disease, including additional congenital anomalies, total prevalence, trends, and association with maternal age. Methods: Cases of Hirschsprung's disease delivered during 1980 to 2009 notified to 31 European Surveillance of Congenital Anomaly registers formed the population-based case-series. Prevalence rates and 95% confidence intervals were calculated as the number of cases per 10,000 births. Multilevel Poisson regression was performed to investigate trends in prevalence, geographical variation and the association with maternal age. Results: There were 1,322 cases of Hirschsprung's disease among 12,146,210 births. The total prevalence was 1.09 (95% confidence interval, 1.03–1.15) per 10,000 births and there was a small but significant increase in prevalence over time (relative risk = 1.01; 95% credible interval, 1.00–1.02; p = 0.004). There was evidence of geographical heterogeneity in prevalence (p < 0.001). Excluding 146 (11.0%) cases with chromosomal anomalies or genetic syndromes, there were 1,176 cases (prevalence = 0.97; 95% confidence interval, 0.91–1.03 per 10,000 births), of which 137 (11.6%) had major structural anomalies. There was no evidence of a significant increased risk of Hirschsprung's disease in cases born to women aged ≥35 years compared with those aged 25 to 29 (relative risk = 1.09; 95% credible interval, 0.91–1.31; p = 0.355). Conclusion: This large population-based study found evidence of a small increasing trend in Hirschsprung's disease and differences in prevalence by geographic location. There was also no evidence of an association with maternal age.
U2 - 10.1002/bdra.23269
DO - 10.1002/bdra.23269
M3 - Article
C2 - 25066220
SN - 1542-0760
VL - 100
SP - 695
EP - 702
JO - Birth Defects Research Part A - Clinical and Molecular Teratology
JF - Birth Defects Research Part A - Clinical and Molecular Teratology
IS - 9
ER -